EBITDA: Income before interest, taxes, depreciation and amortization.
AVANOS MEDICAL, INC. (AVNS) had EBITDA of $12.50M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$175.00M |
|
$-76.80M |
|
$82.90M |
|
$92.10M |
|
$249.50M |
|
$-74.50M |
|
$-1.40M |
|
$-75.90M |
|
$-75.90M |
|
$-76.80M |
|
$-76.80M |
|
$-76.80M |
|
$-76.80M |
|
$-74.50M |
|
|
EBITDA |
$12.50M |
46.30M |
|
46.30M |
|
$-1.66 |
|
$-1.66 |
|
| Balance Sheet Financials | |
$356.00M |
|
$114.30M |
|
$683.00M |
|
$1.04B |
|
$134.60M |
|
$95.70M |
|
$128.10M |
|
$262.70M |
|
$776.30M |
|
$289.70M |
|
$776.30M |
|
46.31M |
|
| Cash Flow Statement Financials | |
$32.50M |
|
$-22.30M |
|
$-32.30M |
|
$107.70M |
|
$90.30M |
|
$-17.40M |
|
$7.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.64 |
|
-- |
|
-- |
|
0.11 |
|
0.14 |
|
52.63% |
|
-42.57% |
|
-42.57% |
|
-- |
|
-43.37% |
|
-43.89% |
|
$14.80M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.58 |
|
1.59 |
|
56.67 |
|
-9.89% |
|
-26.51% |
|
-7.39% |
|
-8.81% |
|
$16.76 |
|
$0.32 |
|
$0.70 |
|